Loading...

Revelation Biosciences, Inc.

REVBWNASDAQ
Healthcare
Biotechnology
$0.01
$0.00(0.00%)

Revelation Biosciences, Inc. REVBW Peers

See (REVBW) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
REVBW$0.01+0.00%1.8MN/A-$4.77N/A
VRTX$445.20+0.00%116.1B-117.75-$3.84N/A
REGN$525.00+0.00%56.8B13.59$39.35+0.16%
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
ALNY$326.09+0.00%42B-152.64-$2.11N/A
ARGX$551.22+0.00%33.1B33.10$16.39N/A
BNTX$106.47+0.00%25.8B-29.37-$3.66N/A
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
RPRX$36.03+0.00%20.2B14.64$2.45+2.40%
DNA-WT$0.27-2.76%18.7BN/AN/AN/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

REVBW vs VRTX Comparison

REVBW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, REVBW stands at 1.8M. In comparison, VRTX has a market cap of 116.1B. Regarding current trading prices, REVBW is priced at $0.01, while VRTX trades at $445.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

REVBW currently has a P/E ratio of N/A, whereas VRTX's P/E ratio is -117.75. In terms of profitability, REVBW's ROE is -0.01%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, REVBW is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for REVBW.

Stock Price Comparison

Loading...

Frequently Asked Questions

;